“…Elucidation of mechanisms responsible for initiating and promoting gene amplification provides opportunities to identify new biomarkers to aid in the diagnosis and prognosis of oral cancer, and may be useful for developing novel therapeutic strategies for patients with OSCC. cronuclei (Balansky et al, 1988;Mohtashamipur et al, 1988;Stoichev et al, 1993;Saunders et al, 2000), lagging chromosomes (Sabharwal et al, 1975;Saunders et al, 2000), as well as chromosomal aneuploidy and various structural chromosome rearrangements, including gene amplification (Lafi and Parry, 1988;Luo et al, 2004). One ongoing problem with treating OSCC is that tumors from the same site within the oral cavity respond differently to identical treatment regimens.…”